Plasma-derived medicinal therapies provide life-saving treatments for a range of mostly rare diseases including hemophilia and immunodeficiencies and serious medical conditions such as shock.
It is important to understand that plasma therapies are intrinsically different from blood components such as red cells, thrombocytes, and so on, obtained from a whole blood donation. These differences center on the way plasma is collected, as well as in the production process of plasma protein therapies. In contrast to whole blood and blood components, plasma-derived medicinal therapies are not directly used for transfusion, but rather undergo an elaborate and well controlled manufacturing process. The following facts highlight some of the principle differences between the two.
Whole blood is pumped by the heart and travels through miles of blood vessels to every part of the body. It is a highly specialized liquid that circulates throughout the body and has these primary functions. It contains:
Plasma protein therapies are manufactured medicinal products with a defined shelf-life that are distributed world-wide. Blood and blood components are labile (constantly changing or unstable) products with a short life-span of a few days and are almost exclusively used locally.